The National Public Health Emergency Team will discuss a link between very rare blood clotting and the AstraZeneca Covid-19 vaccine when it meets later.
The European Medicines Agency has said it should be listed as a possible side effect, however stressed the benefits of the injection continues to outweigh the risk.
The National Immunisation Advisory Committee will consider the findings, and whether new advice needs to be issued.
The UK are to offer alternative vaccines to under 30s due to the risk, while its use is suspended in Norway and Denmark.
